|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 35/768 | |
| C07K 16/18 |
| (11) | Number of the document | 3169341 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15738359.7 |
| Date of filing the European patent application | 2015-07-16 | |
| (97) | Date of publication of the European application | 2017-05-24 |
| (45) | Date of publication and mention of the grant of the patent | 2019-06-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2015/066263 |
| Date | 2015-07-16 |
| (87) | Number | WO 2016/008976 |
| Date | 2016-01-21 |
| (30) | Number | Date | Country code |
| 14306153 | 2014-07-16 | EP |
| (72) |
SILVESTRE, Nathalie, FR
GEIST, Michel, FR
RITTNER, Karola, FR
MARCHAND, Jean-Baptiste, FR
THIOUDELLET, Christine, FR
|
| (73) |
Transgene SA,
Parc d`Innovation Boulevard Gonthier d`Andernach, 67400 Illkirch Graffenstaden,
FR
|
| (54) | ONCOLYTIC VIRUS FOR EXPRESSION OF IMMUNE CHECKPOINT MODULATORS |
| ONCOLYTIC VIRUS FOR EXPRESSION OF IMMUNE CHECKPOINT MODULATORS |